MyeloMATCH Precision Medicine Trials in Myeloid Leukemias Open to Patient Enrollment Across the U.S. and Canada

Umbrella trial design will link multiple NCI-supported studies to allow patients with newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to register to clinical trials throughout the course of their cancer treatment.

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine treatments for adults with acute myeloid leukemia

• Read more